“…For IMDs combined, rates of between 12 and 27% have been documented in Uganda and South Africa, respectively [ 1 , 9 ]. Among people living with HIV/AIDS, IMDs have been associated with a number of other negative outcomes, including accelerated cellular aging [ 10 ], faster HIV disease progression [ 11 , 12 ], poor adherence to medication [ 12 , 13 ], risky sexual behavior [ 13 , 14 ], poor linkage to care for newly diagnosed HIV+ persons [ 15 ], increased HIV transmission (through the promotion of HIV drug resistance) [ 16 ] and impaired academic and social functioning [ 13 ].…”